Trademark: 88676987
Status Date
Monday, June 12, 2023
Filing Date
Friday, November 1, 2019
Published for Opposition
Tuesday, March 17, 2020
Abandoned Date
Monday, June 12, 2023
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma
The wording "GALVUS MET" has no meaning in a foreign language.
"MET"
Jun 12, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Jun 12, 2023
Abandonment - No Use Statement Filed
Nov 18, 2022
Notice Of Approval Of Extension Request E-Mailed
Nov 17, 2022
Sou Extension 5 Granted
Nov 7, 2022
Sou Extension 5 Filed
Nov 16, 2022
Case Assigned To Intent To Use Paralegal
Nov 7, 2022
Sou Teas Extension Received
May 12, 2022
Notice Of Approval Of Extension Request E-Mailed
May 10, 2022
Sou Extension 4 Granted
May 10, 2022
Sou Extension 4 Filed
May 10, 2022
Sou Teas Extension Received
Nov 11, 2021
Notice Of Approval Of Extension Request E-Mailed
Nov 9, 2021
Sou Extension 3 Granted
Nov 9, 2021
Sou Extension 3 Filed
Nov 9, 2021
Sou Teas Extension Received
May 11, 2021
Notice Of Approval Of Extension Request E-Mailed
May 9, 2021
Sou Extension 2 Granted
May 9, 2021
Sou Extension 2 Filed
May 9, 2021
Sou Teas Extension Received
Nov 13, 2020
Notice Of Approval Of Extension Request E-Mailed
Nov 11, 2020
Sou Extension 1 Granted
Nov 11, 2020
Sou Extension 1 Filed
Nov 11, 2020
Sou Teas Extension Received
May 12, 2020
Noa E-Mailed - Sou Required From Applicant
Mar 17, 2020
Official Gazette Publication Confirmation E-Mailed
Mar 17, 2020
Published For Opposition
Feb 26, 2020
Notification Of Notice Of Publication E-Mailed
Feb 7, 2020
Assigned To Lie
Jan 29, 2020
Approved For Pub - Principal Register
Jan 28, 2020
Teas/Email Correspondence Entered
Jan 27, 2020
Correspondence Received In Law Office
Jan 27, 2020
Teas Response To Office Action Received
Jan 15, 2020
Notification Of Non-Final Action E-Mailed
Jan 15, 2020
Non-Final Action E-Mailed
Jan 15, 2020
Non-Final Action Written
Jan 3, 2020
Assigned To Examiner
Nov 5, 2019
New Application Office Supplied Data Entered
Nov 5, 2019
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
